Absolutely Public Relations

The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has selected Denver-based Sapphire Technology, LLC, to receive funding and management assistance.

Fitzsimons Redevelopment Authority (FRA) opens its new $8 million Accelerator facility today, expanding its Bioscience Park Center (BPC) by roughly 50% with this state-of-the-art 37,000-square-foot structure.

Following an extensive national search, Fitzsimons Redevelopment Authority (FRA) has named Steve VanNurden as its new President & CEO. He comes to FRA from Mayo Clinic in Rochester, MN.

The Fitzsimons Redevelopment Authority (FRA) is expanding its Bioscience Park Center (BPC) by roughly 50% with an $8 million, 37,000-square-foot accelerator structure.

The Fitzsimons Redevelopment Authority (FRA) is adding four of the area's most well-known and successful leaders in the Bioscience Industry to its Board of Directors.

The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has selected Ft. Collins, Colorado-based VetDC to receive funding and management assistance to advance its Lead Molecule, VDC 1101.

Tails of the Painted Cats, the 30th Anniversary Art Event Fundraiser for the shelter cats at the Cat Care Society (CCS), are now on display at Santa Fe Art District Galleries through April 30.

Colorado BioScience Association (CBSA) announces Steve Orndorff, President & CEO of Ariel pharmaceuticals, as the new chairperson of the board of directors. Orndorff assumes chairperson responsibilities from Rick Jory, Sandhill Scientific, Inc.

The Joseph Decuis 'Farm to Fork' enterprise just outside Fort Wayne, is now Certified Humane® by Humane Farm Animal Care (HFAC) for both its Gourmet Restaurant and Farming Operations for its Wagyu Beef and and Free-Range Laying Hens.

The Colorado BioScience Association (CBSA) and The Colorado Office of Economic Development and International Trade (OEDIT) have jointly released results of the Bioscience Discovery Evaluation Grant Program (BDEGP).